ENDRA Life Sciences Overview
Latest P/E ratio for ENDRA Life Sciences: -0.75 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-0.75
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, NDRA shows a P/E ratio of -0.75. That is below the Technology sector average of 14.35. Scroll down for historical charts and peer comparison views.
The Technology sector average P/E ratio is about 14.35. ENDRA Life Sciences is at -0.75, which is lower that average. That is roughly 105.2% below the sector mean. Use the comparison chart on this page to see how NDRA stacks up against individual peers as well.
Investors watch NDRA's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. ENDRA Life Sciences's latest reading is -0.75. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has ENDRA Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -0.75) with ownership activity and broader fundamentals.
The Technology average P/E ratio is about 14.35, while NDRA is at -0.75. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
